PTC Therapeutics
PTCTPTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.In September 2009, PTC entered into an agreement with R …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at PTC Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 8/4/2026 | Sell | Klein, Matthew B. | CHIEF EXECUTIVE OFFICER | $68.6 | $705,722 |
| 7/14/2026 | Sell | Gravier, Pierre | CHIEF FINANCIAL OFFICER | $80.4 | $280,743 |
| 7/9/2026 | Sell | Almstead, Neil Gregory | CHIEF TECHNICAL OPS OFFICER | $90.3 | $222,376 |
| 7/9/2026 | Sell | Smith, Mary L. | Director | $90.0 | $1,425,060 |
| 7/7/2026 | Sell | Almstead, Neil Gregory | CHIEF TECHNICAL OPS OFFICER | $88.6 | $2,187,746 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)